Post RFQ
It adopts precise purification technology to effectively reduce harmful impurities, meeting the standards of European and American pharmacopoeias. The fine particle size improves dispersion uniformity in ointment matrix, and its stable chemical structure helps maintain stability during pharmaceutical production. It has good biocompatibility and is well-tolerated by human skin and gastrointestinal tract, and can be directly used in tablet pressing, ointment preparation and other pharmaceutical processes. The production workshop strictly follows GMP specifications to ensure product consistency and safety.

The product has a minimum purity of 99.0%, zinc content of 57.8-58.5%, burn-off loss of 25.2-27.8%, lead content ≤5 ppm, arsenic content ≤2 ppm, cadmium content ≤1 ppm, total microbial count ≤1000 CFU/g, mold and yeast ≤100 CFU/g, no Escherichia coli or Salmonella, particle size D50 of 10-20 μm, and appears as white fine powder. It is packaged in medical-grade 10kg parcels, stored in a dry and避光 environment, and has a shelf life of 2 years.
It is used in preparing external skin care ointments such as zinc ointments for treating eczema and dermatitis, oral zinc supplementation tablets, and auxiliary materials for children's zinc syrup. It can also be used as a pharmaceutical adsorbent for treating mild diarrhea, meeting the quality requirements of global medical regulatory agencies.